RU2017137960A3 - - Google Patents

Download PDF

Info

Publication number
RU2017137960A3
RU2017137960A3 RU2017137960A RU2017137960A RU2017137960A3 RU 2017137960 A3 RU2017137960 A3 RU 2017137960A3 RU 2017137960 A RU2017137960 A RU 2017137960A RU 2017137960 A RU2017137960 A RU 2017137960A RU 2017137960 A3 RU2017137960 A3 RU 2017137960A3
Authority
RU
Russia
Application number
RU2017137960A
Other versions
RU2705991C2 (ru
RU2017137960A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017137960A3 publication Critical patent/RU2017137960A3/ru
Publication of RU2017137960A publication Critical patent/RU2017137960A/ru
Application granted granted Critical
Publication of RU2705991C2 publication Critical patent/RU2705991C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2017137960A 2015-04-01 2015-04-01 Применение тиаоксосоединений для уменьшения содержания аро с3 RU2705991C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/001316 WO2016156912A1 (en) 2015-04-01 2015-04-01 Use of thia oxo compounds for lowering apo c3

Publications (3)

Publication Number Publication Date
RU2017137960A3 true RU2017137960A3 (ru) 2019-05-06
RU2017137960A RU2017137960A (ru) 2019-05-06
RU2705991C2 RU2705991C2 (ru) 2019-11-13

Family

ID=53879725

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017137960A RU2705991C2 (ru) 2015-04-01 2015-04-01 Применение тиаоксосоединений для уменьшения содержания аро с3

Country Status (7)

Country Link
US (1) US20180110747A1 (ru)
JP (1) JP2018510206A (ru)
KR (1) KR20180010181A (ru)
AU (1) AU2015389862B2 (ru)
MX (1) MX2017012641A (ru)
RU (1) RU2705991C2 (ru)
WO (1) WO2016156912A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016173923A1 (en) 2015-04-28 2016-11-03 Pronova Biopharma Norge As Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
IL275002B2 (en) 2017-12-06 2024-04-01 Basf As Fatty acid antecedents for the treatment of nonalcoholic fatty liver disease
CA3101041A1 (en) 2018-05-23 2019-11-28 Northsea Therapeutics B.V. Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease
JP2023554524A (ja) 2020-12-22 2023-12-27 ノースシー セラピューティクス ベスローテン フェンノートシャップ 非アルコール性脂肪性肝炎の治療のための酸素含有構造強化脂肪酸を含む組合せ療法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2726765T3 (es) * 2009-05-08 2019-10-09 Basf As Acidos grasos poliinsaturados para el tratamiento de enfermedades relacionadas con el campo de enfermedades cardiovasculares, metabólicas e inflamatorias
BR112013010890B1 (pt) * 2010-11-05 2020-03-10 Basf As Uso de um composto para a fabricação de um medicamento para tratamento ou prevenção de uma condição de apo b elevado
RU2645075C2 (ru) * 2012-05-07 2018-02-15 Омтера Фармасьютикалс, Инк. Композиции статинов и омега-3 жирных кислот
EP2961384B1 (en) * 2013-02-28 2019-08-28 Basf As A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same

Also Published As

Publication number Publication date
KR20180010181A (ko) 2018-01-30
WO2016156912A1 (en) 2016-10-06
MX2017012641A (es) 2018-06-06
AU2015389862A1 (en) 2017-11-23
US20180110747A1 (en) 2018-04-26
RU2705991C2 (ru) 2019-11-13
AU2015389862B2 (en) 2021-04-15
JP2018510206A (ja) 2018-04-12
RU2017137960A (ru) 2019-05-06

Similar Documents

Publication Publication Date Title
BR112017027056A2 (ru)
BR112017026465A2 (ru)
BR112017026806A2 (ru)
BR112018005621A2 (ru)
RU2017137960A3 (ru)
BR112018002311A2 (ru)
BR0008719B1 (ru)
BR0008132B1 (ru)
BR0205685B1 (ru)
BR0107395B1 (ru)
BR0104748B1 (ru)
BR0010150B1 (ru)
BR0000695B1 (ru)
BR0009942B1 (ru)
BR0009761B1 (ru)
BR0009757B1 (ru)
BR0009717B1 (ru)
BR0009649B1 (ru)
BR0009373B1 (ru)
BR0009349B1 (ru)
BR0009182B1 (ru)
BR0000763F1 (ru)
BR0008874B1 (ru)
BR0008789B1 (ru)
BR0007487B1 (ru)